Search hospitals > Maryland > Hanover
Chesapeake Urology Research Associates
Claim this profileHanover, Maryland 21076
Global Leader in Bladder Cancer
Conducts research for Stress Incontinence
Conducts research for Urinary Incontinence
Conducts research for Bedwetting
Conducts research for Stress Urinary Incontinence
21 reported clinical trials
1 medical researcher
Summary
Chesapeake Urology Research Associates is a medical facility located in Hanover, Maryland. This center is recognized for care of Bladder Cancer, Stress Incontinence, Urinary Incontinence, Bedwetting, Stress Urinary Incontinence and other specialties. Chesapeake Urology Research Associates is involved with conducting 21 clinical trials across 25 conditions. There are 1 research doctors associated with this hospital, such as Rian Dickstein, MD.Area of expertise
1Bladder Cancer
Global LeaderFGFR positive
Stage II
Stage I
2Stress Incontinence
Top PIs
Clinical Trials running at Chesapeake Urology Research Associates
Bladder Cancer
Carcinoma
TAR-210
for Bladder Cancer
The main purpose of this study is to compare the disease-free survival between participants receiving treatment with TAR-210 versus investigator's choice of intravesical chemotherapy for treatment of intermediate-risk NMIBC.
Recruiting2 awards Phase 34 criteria
TAR-200 + Cetrelimab vs BCG
for Bladder Cancer
This trial is testing a new bladder cancer treatment using a special device to deliver a drug directly into the bladder, either alone or with an immune-boosting drug. It targets patients with high-risk bladder cancer who haven't had BCG treatment before. The device ensures a steady release of the drug, while the immune-boosting drug helps the body fight cancer.
Recruiting2 awards Phase 36 criteria
ZH9
for Bladder Cancer
This is a first-in-human, multicenter, Phase 1/1b, 3-part, double-blind study of ZH9 in patients with recurrent NMIBC who are eligible for intravesical therapy. In Part 1, the safety, tolerability, and pharmacology of ZH9 IVI will be evaluated in a single ascending dose (SAD) patient cohort. In Part 2, the safety, tolerability, and pharmacology of ZH9 oral prime followed by ZH9 IVI will be evaluated in 2 patient cohorts at the doses and schedule established in Part 1. In Part 3, the safety, pharmacology, and clinical efficacy of ZH9 will be further evaluated in 2 expansion cohorts of patients with recurrent intermediate- and high-risk NMIBC.
Recruiting1 award Phase 1
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Chesapeake Urology Research Associates?
Chesapeake Urology Research Associates is a medical facility located in Hanover, Maryland. This center is recognized for care of Bladder Cancer, Stress Incontinence, Urinary Incontinence, Bedwetting, Stress Urinary Incontinence and other specialties. Chesapeake Urology Research Associates is involved with conducting 21 clinical trials across 25 conditions. There are 1 research doctors associated with this hospital, such as Rian Dickstein, MD.